474
Views
28
CrossRef citations to date
0
Altmetric
Theme: Emerging Molecular Diagnostic Technologies - Review

Breast cancer stem cell enrichment and isolation by mammosphere culture and its potential diagnostic applications

&
Pages 49-60 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chun Hu, Liang Xu, Shujing Liang, Zhiying Zhang, Yanyun Zhang & Fengchun Zhang. (2016) Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer. Journal of Drug Targeting 24:5, pages 422-432.
Read now

Articles from other publishers (27)

Utsav Sen, Shanooja Shanavas, Apoorva H. Nagendra, Muhammad Nihad, Debajit Chaudhury, Hari K. Rachamalla, Rajkumar Banerjee, Sudheer Shenoy P & Bipasha Bose. (2022) Significance of Oct‐4 transcription factor as a pivotal therapeutic target for CD44 + /24 − mammary tumor initiating cells: Aiming at the root of the recurrence . Cell Biology International 47:4, pages 742-753.
Crossref
Mingming Wu, Xiao Zhang, Weijie Zhang, Linlin Yan, Xiangtian Liu, Min Zhang, Yueyin Pan, Peter E. Lobie, Xinghua Han & Tao Zhu. (2023) Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells. Cell Communication and Signaling 21:1.
Crossref
Mohammad-esmaeil Akbari, Mousa Ghelichi-Ghojogh, Zahra Nikeghbalian, Maryam Karami, Atieh Akbari, Mehrdad Hashemi, Saghi Nooraei, Mohsen Ghiasi, Mohammad Fararouei & Farid Moradian. (2022) Neoadjuvant VS adjuvant chemotherapy in patients with locally advanced breast cancer; a retrospective cohort study. Annals of Medicine and Surgery 84, pages 104921.
Crossref
Theodoros Karalis, Andrew K. Shiau, Timothy C. Gahman, Spyros S. Skandalis, Carl-Henrik Heldin & Paraskevi Heldin. (2022) Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells. Cancers 14:23, pages 5800.
Crossref
Priya Kundu & Bhavani S. Shankar. (2022) Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition. Biochimica et Biophysica Acta (BBA) - General Subjects 1866:11, pages 130215.
Crossref
Liuyong Pang, Sanhong Liu, Zhong Zhao, Tianhai Tian, Xinan Zhang & Qiuying Li. (2022) Growth dynamics of breast cancer stem cells: effects of self-feedback and EMT mechanisms. Theory in Biosciences 141:3, pages 297-311.
Crossref
Hao Hu, Yuan Xiang, Xiao-Yu Zhang, Yang Deng, Fu-Jian Wan, You Huang, Xing-Hua Liao & Tong-Cun Zhang. (2022) CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker. Oncology Reports 48:4.
Crossref
Anan A. Ishtiah & Badrul Hisham Yahaya. 2022. Stem Cell Assays. Stem Cell Assays 475 484 .
Ya-Hui Wang, Yu-Tzu Chan, Tsai-Hsien Hung, Jung-Tung Hung, Ming-Wei Kuo, Sheng-Hung Wang, Yenlin Huang, Yu-Ju Lin, Shin-Cheh Chen, Jyh-Cherng Yu, Jen-Chine Wu, John Yu & Alice L. Yu. (2021) Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation. Oncogene 40:16, pages 2858-2871.
Crossref
Naizhen Zhou, Xiaoe Ma, Katrien V. Bernaerts, Pengfei Ren, Wanjun Hu & Tianzhu Zhang. (2020) Expansion of Ovarian Cancer Stem-like Cells in Poly(ethylene glycol)-Cross-Linked Poly(methyl vinyl ether- alt -maleic acid) and Alginate Double-Network Hydrogels . ACS Biomaterials Science & Engineering 6:6, pages 3310-3326.
Crossref
Elnaz Saberi Ansar, Changiz Eslahchii, Mahsa Rahimi, Lobat Geranpayeh, Marzieh Ebrahimi, Rosa Aghdam & Gwenneg Kerdivel. (2019) Significant random signatures reveals new biomarker for breast cancer. BMC Medical Genomics 12:1.
Crossref
Saghar Yousefnia, Kamran Ghaedi, Farzad Seyed Forootan & Mohammad Hossein Nasr Esfahani. (2019) Characterization of the stemness potency of mammospheres isolated from the breast cancer cell lines . Tumor Biology 41:8, pages 101042831986910.
Crossref
Yunhee Cho, Hyeok Gu Kang, Seok-Jun Kim, Seul Lee, Sujin Jee, Sung Gwe Ahn, Min Jueng Kang, Joon Seon Song, Joon-Yong Chung, Eugene C. Yi & Kyung-Hee Chun. (2018) Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death & Differentiation 25:10, pages 1781-1795.
Crossref
Zhihong Cai, Yijing Cao, Yichen Luo, Haobin Hu & Hui Ling. (2018) Signalling mechanism(s) of epithelial–mesenchymal transition and cancer stem cells in tumour therapeutic resistance. Clinica Chimica Acta 483, pages 156-163.
Crossref
Sara Cunha, Min Jia & Serhiy Souchelnytskyi. (2018) Exposure to EGF and 17β‑estradiol irreversibly affects the proliferation and transformation of MCF7 cells but is not sufficient to promote tumor growth in a xenograft mouse model upon withdrawal of exposure. International Journal of Molecular Medicine.
Crossref
Xiaotang Yu, Fan Zhang, Jun Mao, Ying Lu, Jiazhi Li, Wei Ma, Shujun Fan, Chunying Zhang, Qing Li, Bo Wang, Bo Song & Lianhong Li. (2017) Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer. Oncotarget 8:58, pages 98798-98811.
Crossref
Feixue Feng, Jianping Zhang, Xiaoxuan Fan, Fang Yuan, Yinghao Jiang, Ruihua Lv & Yanxia Ma. (2017) Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells. Oncology Letters 14:3, pages 2947-2953.
Crossref
Kerri W. Kwist & Brian W. Booth. 2017. Engineering 3D Tissue Test Systems. Engineering 3D Tissue Test Systems 249 262 .
Xiaoti Lin, Weiyu Chen, Fengqin Wei, Binhua P. Zhou, Mien-Chie Hung & Xiaoming Xie. (2017) POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells. International Journal of Cancer 140:11, pages 2517-2525.
Crossref
Oanh Thi-Kieu Nguyen, Anh Nguyen-Tu Bui, Ngoc Bich Vu & Phuc Van Pham. (2016) Overexpress of CD47 does not alter the stemness of MCF-7 breast cancer cells. Biomedical Research and Therapy 3:9.
Crossref
DOM-GENE TU, YUN YU, CHE-HSIN LEE, YU-LIANG KUO, YIN-CHE LU, CHI-WEN TU & WEN-WEI CHANG. (2016) Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor. Oncology Letters 11:4, pages 2934-2940.
Crossref
LIANG XU, LE ZHANG, CHUN HU, SHUJING LIANG, XIAOCHUN FEI, NINGNING YAN, YANYUN ZHANG & FENGCHUN ZHANG. (2016) WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells. International Journal of Oncology 48:3, pages 1175-1186.
Crossref
Ryosuke Iwai, Yasushi Nemoto & Yasuhide Nakayama. (2016) Preparation and characterization of directed, one-day-self-assembled millimeter-size spheroids of adipose-derived mesenchymal stem cells. Journal of Biomedical Materials Research Part A 104:1, pages 305-312.
Crossref
Yunhee Cho, Hyun-Woo Lee, Hyeok-Gu Kang, Hye-Young Kim, Seok-Jun Kim & Kyung-Hee Chun. (2015) Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Oncotarget 6:11, pages 8709-8721.
Crossref
Phuc Van PhamPhuc Van Pham. 2015. Breast Cancer Stem Cells & Therapy Resistance. Breast Cancer Stem Cells & Therapy Resistance 41 55 .
Phuc Van PhamPhuc Van Pham. 2015. Breast Cancer Stem Cells & Therapy Resistance. Breast Cancer Stem Cells & Therapy Resistance 5 24 .
Che-Hsin Lee, Yu-Ting Wu, Hung-Chun Hsieh, Yun Yu, Alice L. Yu & Wen-Wei Chang. (2014) Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells. Biochimie 104, pages 117-126.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.